• Return to Headlines

Relatively Good Performance Detected in Shares of Esperion Therape in the Biotechnology Industry (ESPR , FLXN , AIMT , AMAG , EXAS )

By Shiri Gupta

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming. This is what we found:

Esperion Therape (NASDAQ:ESPR ) ranks first with a gain of 7.55%; Flexion Therapeu (NASDAQ:FLXN ) ranks second with a gain of 7.10%; and Aimmune Therapeu (NASDAQ:AIMT ) ranks third with a gain of 5.18%.

Amag Pharmaceuti (NASDAQ:AMAG ) follows with a gain of 4.65% and Exact Sciences (NASDAQ:EXAS ) rounds out the top five with a gain of 4.37%.

SmarTrend recommended that subscribers consider buying shares of Exact Sciences on March 20th, 2020 as our technology indicated a new Uptrend was in progress when shares hit $52.08. Since that recommendation, shares of Exact Sciences have risen 19.6%. We continue to monitor Exact Sciences for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: relative performance esperion therape flexion therapeu aimmune therapeu amag pharmaceuti exact sciences